Registries for Evaluating Patient Outcomes

Registries for Evaluating Patient Outcomes
Author :
Publisher : Government Printing Office
Total Pages : 385
Release :
ISBN-10 : 9781587634338
ISBN-13 : 1587634333
Rating : 4/5 (333 Downloads)

Book Synopsis Registries for Evaluating Patient Outcomes by : Agency for Healthcare Research and Quality/AHRQ

Download or read book Registries for Evaluating Patient Outcomes written by Agency for Healthcare Research and Quality/AHRQ and published by Government Printing Office. This book was released on 2014-04-01 with total page 385 pages. Available in PDF, EPUB and Kindle. Book excerpt: This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.


Registries for Evaluating Patient Outcomes Related Books

Registries for Evaluating Patient Outcomes
Language: en
Pages: 385
Authors: Agency for Healthcare Research and Quality/AHRQ
Categories: Medical
Type: BOOK - Published: 2014-04-01 - Publisher: Government Printing Office

GET EBOOK

This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase unders
Challenges for the FDA
Language: en
Pages: 128
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2007-10-02 - Publisher: National Academies Press

GET EBOOK

As the principal agency regulating food, drugs, medical devices, and biological products used by Americans, the U.S. Food and Drug Administration (FDA) serves o
Drug Safety in Developing Countries
Language: en
Pages: 656
Authors: Yaser Mohammed Al-Worafi
Categories: Medical
Type: BOOK - Published: 2020-06-03 - Publisher: Academic Press

GET EBOOK

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety p
Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis
Language: en
Pages: 0
Authors: World Health Organization
Categories: Medical
Type: BOOK - Published: 2015-04-20 - Publisher:

GET EBOOK

This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals worki
The Future of Drug Safety
Language: en
Pages: 347
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2007-03-27 - Publisher: National Academies Press

GET EBOOK

In the wake of publicity and congressional attention to drug safety issues, the Food and Drug Administration (FDA) requested the Institute of Medicine assess th